Cognitive Behavioral Therapy for Fear of Recurrence After Immunotherapy

This study is looking at how cognitive behavioral therapy (a type of talk therapy that helps you change unhelpful thoughts and behaviors) can help people who are worried about their cancer coming back after they stop immunotherapy (a treatment that uses your body's own immune system to fight cancer). You can join if you are 21 or older, speak English fluently, have been diagnosed with cancer, and have received immunotherapy. The main goal is to see if this therapy can reduce your fear of recurrence (cancer coming back) within 3 months. The study is currently recruiting participants.

Study design
This interventional study plans to enroll 100 participants. It will test cognitive behavioral therapy delivered through telemedicine.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 3 months, suggesting follow-up for at least this duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04761328

Fear of Recurrence and Stopping Immunotherapy

Recruiting
NAAges 21+InterventionalSupportive care
University of Pittsburgh
~100 participants
Updated 2025-12-05 on ClinicalTrials.gov
What's tested:cognitive behavioral therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Reduce fear of recurrence
Measured over 3 months
Cognitive Behavioral Therapy
1 sites across 1 states
Pennsylvania1
  • Jason Luke · PRINCIPAL_INVESTIGATOR · Hillman Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 21 years and older
Fluent in English
Diagnosis of cancer and history of treatment with immunotherapy

Exclusion

Active suicidal ideation, delusions or hallucinations
  • Reduce fear of recurrence3 months

    Change by 50%